Recall Atlas
Drugs & medicalClass II

Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC…

CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution

Read the official notice →
Date
2026-03-11
Country
United States
Brand
Harbin Jixianglong Biotech Co., Ltd.
Product
Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g,…
Classification
Class II
Units
Nationwide within the United States
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in the United States

  1. 2026-03-11
  2. US
    Drugs & medicalClass II

    Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc.,…

    Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing

    FDA · DrugRising Pharma Holding, Inc.Nationwide within the U.SOfficial notice →
  3. US
    Drugs & medicalClass II

    The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major…

    Defective container; inadequately sealed blister packaging.

    FDA · DrugThe Harvard Drug Group LLCNationwide US.Official notice →
  4. US
    Drugs & medicalClass III

    Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for:…

    Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

    FDA · DrugCipla USA, Inc.U.S.A. NationwideOfficial notice →
  5. US
    Drugs & medicalClass II

    ACME UNITED CORPORATION recalls Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), 100 Towelettes, Manufactured by: Acme United Corporation, 1 Waterview…

    CGMP Deviations

    FDA · DrugACME UNITED CORPORATIONNationwide within the United StatesOfficial notice →
  6. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC:…

    Failed Dissolution Specifications

    FDA · DrugTeva Pharmaceuticals USA, IncNationwideOfficial notice →
  7. 2026-03-04
  8. US
    Drugs & medicalClass II

    Remel, Inc recalls Campy CVA Medium 100/PK, R01272

    Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

    FDA · DeviceRemel, IncUS Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.Official notice →
See all drugs & medical recalls →